Targeting CDK9 for treatment of colorectal cancerMuhammed H. Rahaman, Shudong Wang|Molecular Oncology|2019Cited by 57
Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73Frankie Lam, Shudong Wang|Oncotarget|2014Cited by 53
Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and EvaluationBiruk Sintayehu Fanta, Shudong Wang|Molecules|2023Cited by 8